Crossmark

Umbilical cord as a long-term source of activatable mesenchymal stromal cells for immunomodulation

Published Online: 2019-09-23

Published Print: 2019-12

Authors

Selich, Anton

Zimmermann, Katharina

Tenspolde, Michel

Dittrich-Breiholz, Oliver

von Kaisenberg, Constantin

Schambach, Axel

Rothe, Michael https://orcid.org/0000-0002-6813-4705
Funding

Funding for this research was provided by:

Deutsche Forschungsgemeinschaft (RO 5102/1-1, Cluster of Excellence REBIRTH Exc 62/1, SFB 738)

Niedersächsischen Krebsgesellschaft
License Information

Text and Data Mining valid from 2019-09-23

Version of Record valid from 2019-09-23
More Information

Article History

Received: 25 April 2019

Revised: 2 August 2019

Accepted: 7 August 2019

First Online: 23 September 2019

Ethics approval and consent to participate

: Human UC was obtained from term deliveries (38–40 weeks) and PBMCs after written informed consent, in accordance with the standards of the Hannover Medical School Ethics Committee and with the Helsinki Declaration of 1975, as revised in 1983.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current